Stockreport

Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF FDA response expected on or before June 30, 2020 Acasti also received notice of issuance of a Composition of Matter Patent in Hong Kong LAVAL, Quebec, April 30, 2020 [Read more]